PPT-Best Practices in the Diagnosis and Treatment of Bacteremia

Acute Care AHRQ Safety Program for Improving Antibiotic Use AHRQ Pub No 17200028EF November 2019 Objectives Review recommendations for appropriate blood culture collection Develop organismspecific management recommendations . Anaemia. Prof. Aziz-ur-Rehman. Introduction. Very common problem. Subtle or no symptoms, usually incidental finding. Various causes; ID is the commonest. Simple iron replacement is not the solution. Investigate before starting treatment. Robin W Paton PhD FRCS . FRCS. (Orthopaedic). BOTA 2015. What is over-diagnosis? . First do no harm!. Disease: . A disorder of structure or function that is not simply a direct result of physical injury!. CDC’s Antimicrobial Resistance Laboratory Network in Nevada. Julia (Julie) A. Kiehlbauch, Ph.D., D(ABMM). Objectives. At the completion of the presentation, attendees will be able to:. Compare and contrast bacteremia, sepsis and asymptomatic bacteremia. Acute Care. AHRQ Safety Program for Improving Antibiotic . Use. AHRQ Pub. No. 17(20)-0028-EF. November 2019 . Objectives. Describe . the approach to diagnosing . cellulitis.. Describe the microbiology of cellulitis and how that informs empiric therapy.. Clostridioides difficile . Infections. Acute Care. AHRQ Safety Program for Improving Antibiotic . Use. AHRQ Pub. No. 17(20)-0028-EF. November 2019 . Objectives. Discuss the importance of judicious . C. difficile . Acute Care. AHRQ Safety Program for Improving Antibiotic Use. AHRQ Pub. No. 17(20)-0028-EF. November 2019 . Objectives. Discuss . the . approach to diagnosing . ventilator-associated pneumonia (VAP) . Presented by Maggie Wong (AMS pharmacist). Co-investigators: Dr. K . Afra. , Dr. K Tan, Kieran Shah. Background . Objectives. Methods. Results. Demographics of patients. Treatment received. Outcomes. Presented by Wendy Gerstein, . Md. 5/23/2018. Why this topic?. Point of interest – over the years I have seen some widely variable work-ups and treatment plans.. Guidelines are difficult to interpret for specific treatment of GNR bacteremia.. 195 core concept has been on a nonlinear, sometimes circular, but generally forward-moving theoretical and clinical journey.Darley’s conceptual and nosologic contributionsits bookend disorders
1 Ju ne 2019 The New Standard Provider FAQ Early diagnosis of HIV infection, followed by prompt antiretroviral therapy ( ART ) initiation , expands the concept of universal ART . There are cle 1 Presenter��2&#x/BBo;&#xx [1;•.0;ࠥ ;ͷ.;刓&#x 547;&#x.162; 41; .16; ];&#x/Sub;&#xtype;&#x /Fo;&#xoter;&#x /Ty;&#xpe /;&#xPagi;&#xnati;&#xon 0;&#x/BBo;&#xx [1;& Joanne Aitken, Danny Youlden, Cate Brown, Andy Moore. Cancer Council Queensland. Queensland Children’s Hospital. Background. t-AML occurs in patients exposed to cytotoxic chemotherapy and/or radiotherapy . Alhashash F, Weston V, Diggle M, McNally A. Multidrug-Resistant Escherichia coli Bacteremia. Emerg Infect Dis. 2013;19(10):1699-1701. https://doi.org/10.3201/eid1910.130309. Blood Culture Identification Panel 2 (BCID2) and Antimicrobial Stewardship Interventions on Time to Optimal Antimicrobial Therapy in Patients with Positive Blood Cultures . Isaac Nichols. 1. , . PharmD.